Trials / Conditions / Laser in Situ Keratomileusis
Laser in Situ Keratomileusis
3 registered clinical trials studyying Laser in Situ Keratomileusis.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Patient Reported Outcomes With LASIK: PROWL-2 NCT01655420 | Food and Drug Administration (FDA) | — |
| Completed | Patient-Reported Outcomes With LASIK:PROWL-1 NCT01526291 | Food and Drug Administration (FDA) | — |
| Completed | Study of Cyclosporine in Post-LASIK Patients NCT00991458 | Allergan | Phase 2 |